TKTL2 Antikörper (AA 1-300) (HRP)
Kurzübersicht für TKTL2 Antikörper (AA 1-300) (HRP) (ABIN7172900)
Target
Alle TKTL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 1-300
- 
                                            Kreuzreaktivität
- Human
- 
                                            Aufreinigung
- >95%, Protein G purified
- 
                                            Immunogen
- Recombinant Human Transketolase-like protein 2 protein (1-300AA)
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Lagerung
- -20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - TKTL2 (Transketolase-Like 2 (TKTL2))
- 
                                            Andere Bezeichnung
- TKTL2
- 
                                            Hintergrund
- 
                        Background: Plays an essential role in total transketolase activity and cell proliferation in cancer cells, after transfection with anti-TKTL1 siRNA, total transketolase activity dramatically decreases and proliferation was significantly inhibited in cancer cells. Plays a pivotal role in carcinogenesis. Aliases: TKTL2 antibody, Transketolase-like protein 2 antibody, EC 2.2.1.1 antibody 
- 
                                            UniProt
- Q9H0I9
 Target
- 
                    
 
                                     
                                     
                                    